Tivozanib Clinical Trials

3 actively recruiting trials across 3 locations

Also known as: AV951, AV951 cpd, KRN 951, KRN-951, KRN951, UNII-172030934T

Filter by location:

Phoenix, Arizona1 trial

Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer

Cancer Center at Saint Joseph's

Phase 3

Bethesda, Maryland1 trial

Evaluating Efficacy of Tivozanib (AV-951) in Biliary Tract Cancers

National Institutes of Health Clinical Center

Phase 1/2

Boston, Massachusetts1 trial

Phase 2 Study of Combination Tivozanib and Nivolumab in Advanced Non-Clear Cell Renal Cell Carcinoma

Beth Israel Deaconess Medical Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.